Prognostic CpG Methylation Biomarkers Identified by Methylation Array in Esophageal Squamous Cell Carcinoma Patients

Background: Esophageal squamous cell carcinoma (ESCC) is an aggressive cancer with poor prognosis. We aimed to identify a panel of CpG methylation biomarkers for prognosis prediction of ESCC patients. Methods: Illumina's GoldenGate methylation array, supervised principal components, Kaplan-Meie...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuo, I-Ying, Chang, Jia-Ming, Jiang, Shih-Sheng, Chen, Chung-Hsin, Chang, I-Shou, Sheu, Bor-Shyang, Lu, Pei-Jung, Chang, Wei-Lun, Lai, Wu-Wei, Wang, Yi-Ching
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4057483/
https://www.ncbi.nlm.nih.gov/pubmed/24936140
http://dx.doi.org/10.7150/ijms.7405